Information about Pharmavector Consultancy
My details
*
*
*

Pharmavector Consultancy (BV)

NL

86016407

Company information

Status
Active

KVK number

86016407

VAT Number

NL 863833421 B01
Established
23-03-2022
Last balance sheet year
2024
Company size
Micro 0 FTE
Legal form
Besloten Vennootschap (BV)
RSIN number
863833421
Principal activity
Activities of organisational consultancy firms
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharmavector Consultancy

2024 2023 2022
Balance sheet
Balance sheet total € 25.945 -10% € 28.888 87% € 15.408
Equity € 22.223 67% € 13.270 280% € 3.491
Debts € 3.722 -76% € 15.618 31% € 11.917
Other
Employees 0 0 0

Frequently asked questions

What is the KVK number of Pharmavector Consultancy?
The KVK number of Pharmavector Consultancy is 86016407
What is the VAT number of Pharmavector Consultancy?
The VAT number of Pharmavector Consultancy is NL 863833421 B01.
Wat is the PEPPOL ID of Pharmavector Consultancy?
There is no information available about the PEPPOL ID of Pharmavector Consultancy or the company is not yet registered on the PEPPOL network.
When was Pharmavector Consultancy founded?
Pharmavector Consultancy was founded on 23-03-2022.
What is the address of Pharmavector Consultancy?
The current registered office of Pharmavector Consultancy is located at Hoefijzerlaan 3, 3981 GK Bunnik.
When was the last time Pharmavector Consultancy filed their annual financial statements?
The most recent financial statements of Pharmavector Consultancy were filed on 31-12-2024.
How many employees does Pharmavector Consultancy have?
There are currently no employees working at Pharmavector Consultancy or no workforce information is available.
What is the annual turnover of Pharmavector Consultancy?
There is no turnover available for Pharmavector Consultancy.

Sources